Pallab Pramanik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pallab Pramanik has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ariful Islam
Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, India
2 shared publications - Kalyani Pathak
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, 786004, Assam, India
2 shared publications - Abhishek Parasar
Pratiksha Institute of Pharmaceutical Sciences
1 shared publication Aparoop Das
1 shared publication- Aparoop Das
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, 786004, Assam, India
1 shared publication Ashish Ranjan Bharadwaj
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 17 March 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 9
Nanoparticles in the fight against antimicrobial challenges: A comprehensive review
- 17 March 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 9
Top Cited PapersOpen AccessNanoparticles in the fight against antimicrobial challenges: A comprehensive review
- Open Access
- 29 December 2023
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 4 (6) , 1135-1167
3D printing in biomedicine: advancing personalized care through additive manufacturing
The integration of three-dimensional (3D) printing techniques into the domains of biomedical research and personalized medicine highlights the evolving paradigm shifts within contemporary healthcare. This technological advancement signifies potential breakthroughs in patient-specific therapeutic interventions and innovations. This systematic review offers a critical assessment of the existing literature, elucidating the present status, inherent challenges, and prospective avenues of 3D printing in augmenting biomedical applications and formulating tailored medical strategies. Based on an exhaustive literature analysis comprising empirical studies, case studies, and extensive reviews from the past decade, pivotal sectors including tissue engineering, prosthetic development, drug delivery systems, and customized medical apparatuses are delineated. The advent of 3D printing provides precision in the fabrication of patient-centric implants, bio-structures, and devices, thereby mitigating associated risks. Concurrently, it facilitates the ideation of individualized drug delivery paradigms to optimize therapeutic outcomes. Notwithstanding these advancements, issues concerning material biocompatibility, regulatory compliance, and the economic implications of avant-garde printing techniques persist. To fully harness the transformative potential of 3D printing in healthcare, collaborative endeavors amongst academicians, clinicians, industrial entities, and regulatory bodies are paramount. With continued research and innovation, 3D printing is poised to redefine the trajectories of biomedical science and patient-centric care. The paper aims to justify the research objective of whether to what extent the integration of 3D printing technology in biomedicine enhances patient-specific treatment and contributes to improved healthcare outcomes.
- 29 December 2023
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 4 (6) , 1135-1167
Open Access3D printing in biomedicine: advancing personalized care through additive manufacturing
The integration of three-dimensional (3D) printing techniques into the domains of biomedical research and personalized medicine highlights the evolving paradigm shifts within contemporary healthcare. This technological advancement signifies potential breakthroughs in patient-specific therapeutic interventions and innovations. This systematic review offers a critical assessment of the existing literature, elucidating the present status, inherent challenges, and prospective avenues of 3D printing in augmenting biomedical applications and formulating tailored medical strategies. Based on an exhaustive literature analysis comprising empirical studies, case studies, and extensive reviews from the past decade, pivotal sectors including tissue engineering, prosthetic development, drug delivery systems, and customized medical apparatuses are delineated. The advent of 3D printing provides precision in the fabrication of patient-centric implants, bio-structures, and devices, thereby mitigating associated risks. Concurrently, it facilitates the ideation of individualized drug delivery paradigms to optimize therapeutic outcomes. Notwithstanding these advancements, issues concerning material biocompatibility, regulatory compliance, and the economic implications of avant-garde printing techniques persist. To fully harness the transformative potential of 3D printing in healthcare, collaborative endeavors amongst academicians, clinicians, industrial entities, and regulatory bodies are paramount. With continued research and innovation, 3D printing is poised to redefine the trajectories of biomedical science and patient-centric care. The paper aims to justify the research objective of whether to what extent the integration of 3D printing technology in biomedicine enhances patient-specific treatment and contributes to improved healthcare outcomes.